{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:28:43Z","timestamp":1782602923707,"version":"3.54.5"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.cll.2018.03.002","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T18:22:40Z","timestamp":1526408560000},"page":"343-355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Molecular Diagnostics in the Neoplasms of Small Intestine and Appendix"],"prefix":"10.1016","volume":"38","author":[{"given":"Yingtao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Zulfiqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"Bluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarpreet","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafic","family":"Beydoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cll.2018.03.002_bib1","series-title":"Cancer: principles and practice of oncology","first-page":"1186","article-title":"Cancer of the small intestine","author":"Zeh","year":"2008"},{"key":"10.1016\/j.cll.2018.03.002_bib2","series-title":"WHO classification of tumours of the digestive system","first-page":"95","author":"Bosman","year":"2010"},{"key":"10.1016\/j.cll.2018.03.002_bib3","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/j.1572-0241.2006.00625.x","article-title":"Adenocarcinoma of the small bowel: a 60-yr perspective derived from M. D. Anderson Cancer Center Tumor Registry","volume":"101","author":"Verma","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cll.2018.03.002_bib4","series-title":"Odze and Goldblum surgical pathology of the GI tract, liver, biliary tract and pancreas","first-page":"722","article-title":"Epithelial neoplasms of the small intestine","author":"Noffsinger","year":"2015"},{"issue":"3","key":"10.1016\/j.cll.2018.03.002_bib5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1200\/JCO.2007.12.5906","article-title":"KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab","volume":"26","author":"Li\u00e8vre","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cll.2018.03.002_bib6","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/(SICI)1097-0142(19970501)79:9<1804::AID-CNCR24>3.0.CO;2-0","article-title":"The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors","volume":"79","author":"Younes","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.cll.2018.03.002_bib7","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/modpathol.2016.40","article-title":"Clinicopathologic and prognostic associations of KRAS and BRAF mutations in small intestinal adenocarcinoma","volume":"29","author":"Jun","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib8","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jamaoncol.2017.1051","article-title":"Genomic profiling of small-bowel adenocarcinoma","volume":"3","author":"Schrock","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cll.2018.03.002_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/his.12469","article-title":"Do serrated neoplasms of the small intestine represent a distinct entity? Pathological findings and molecular alterations in a series of 13 cases","volume":"66","author":"Rosty","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.cll.2018.03.002_bib10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/(SICI)1097-0215(19970207)70:4<390::AID-IJC3>3.0.CO;2-R","article-title":"Mutations of the Ki-ras, p53 and APC genes in adenocarcinomas of the human small intestine","volume":"70","author":"Arai","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cll.2018.03.002_bib11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/gut.50.2.218","article-title":"An insight into the genetic pathway of adenocarcinoma of the small intestine","volume":"50","author":"Wheeler","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cll.2018.03.002_bib12","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/jcp.56.12.898","article-title":"Immunohistochemical analysis of adenocarcinoma of the small intestine: a tissue microarray study","volume":"56","author":"Svrcek","year":"2003","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1042\/BST0330672","article-title":"The role of the Wnt signalling pathway in colorectal tumorigenesis","volume":"33","author":"Behrens","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.cll.2018.03.002_bib14","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/onc.2016.304","article-title":"Wnt signaling in cancer","volume":"36","author":"Zhan","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.cll.2018.03.002_bib15","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1038\/bjc.2013.677","article-title":"Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study","volume":"109","author":"Aparicio","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cll.2018.03.002_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1309\/AJCPS54RTFCTHGWX","article-title":"Combined loss of E-cadherin and aberrant beta-catenin protein expression correlates with a poor prognosis for small intestinal adenocarcinomas","volume":"139","author":"Lee","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s004280050084","article-title":"Reciprocity between membranous and nuclear expression of beta-catenin in colorectal tumours","volume":"431","author":"Hao","year":"1997","journal-title":"Virchows Arch"},{"key":"10.1016\/j.cll.2018.03.002_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13402-011-0024-x","article-title":"Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications","volume":"34","author":"Zaanan","year":"2011","journal-title":"Cell Oncol (Dordr)"},{"key":"10.1016\/j.cll.2018.03.002_bib19","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/cncr.11197","article-title":"Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine","volume":"97","author":"Planck","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.cll.2018.03.002_bib20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/sj.bjc.6605449","article-title":"Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine","volume":"102","author":"Overman","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cll.2018.03.002_bib21","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0002-9440(10)63932-6","article-title":"The relationship between hypomethylation and CpG island methylation in colorectal neoplasia","volume":"162","author":"Bariol","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/modpathol.2010.223","article-title":"Genetics and epigenetics of small bowel adenocarcinoma: the interactions of CIN, MSI, and CIMP","volume":"24","author":"Warth","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.onc.1205041","article-title":"Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene","volume":"21","author":"Bl\u00e4ker","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.cll.2018.03.002_bib24","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ejca.2014.04.007","article-title":"ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma","volume":"50","author":"Laforest","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cll.2018.03.002_bib25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.MP.0000057246.03448.26","article-title":"Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases","volume":"16","author":"McCarthy","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib26","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/sj.bjc.6605898","article-title":"Cetuximab in small bowel adenocarcinoma: a new friend?","volume":"103","author":"Santini","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cll.2018.03.002_bib27","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/gut.2009.196428","article-title":"Molecular characterisation and cetuximab-based treatment in a patient with refractory small bowel adenocarcinoma","volume":"59","author":"De Dosso","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.cll.2018.03.002_bib28","doi-asserted-by":"crossref","first-page":"e9672","DOI":"10.1097\/MD.0000000000009672","article-title":"Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma: case report and literature review","volume":"97","author":"Falcone","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.cll.2018.03.002_bib29","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00384-013-1689-6","article-title":"Molecular alterations of EGFR in small intestinal adenocarcinoma","volume":"28","author":"Wang","year":"2013","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.cll.2018.03.002_bib30","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cll.2018.03.002_bib31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/AJCP\/AQX070","article-title":"Could the PD-1 pathway be a potential target for treating small intestinal adenocarcinoma?","volume":"148","author":"Thota","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib32","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00004836-198906000-00015","article-title":"Adenocarcinoma of the jejunum in association with celiac sprue","volume":"11","author":"Straker","year":"1989","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cll.2018.03.002_bib33","first-page":"1535","article-title":"Small bowel adenocarcinomas in celiac disease follow the CIM-MSI pathway","volume":"24","author":"Bergmann","year":"2010","journal-title":"Oncol Rep"},{"key":"10.1016\/j.cll.2018.03.002_bib34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/his.12908","article-title":"Medullary carcinoma of the small bowel","volume":"69","author":"Brcic","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.cll.2018.03.002_bib35","series-title":"Molecular surgical pathology","first-page":"1","article-title":"Molecular pathology of colorectal cancer","author":"Bosman","year":"2013"},{"key":"10.1016\/j.cll.2018.03.002_bib36","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1097\/MIB.0000000000000112","article-title":"Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular study","volume":"20","author":"Svrcek","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cll.2018.03.002_bib37","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/modpathol.2015.57","article-title":"Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2)","volume":"28","author":"Hechtman","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib38","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1158\/0008-5472.CAN-16-0658","article-title":"The genomic landscape of pancreatic and periampullary adenocarcinoma","volume":"76","author":"Sandhu","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.cll.2018.03.002_bib39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4251\/wjgo.v9.i10.407","article-title":"Ampullary cancer of intestinal origin and duodenal cancer: a logical clinical and therapeutic subgroup in periampullary cancer","volume":"9","author":"Chandrasegaram","year":"2017","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.cll.2018.03.002_bib40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/gm357","article-title":"Cancer of the ampulla of Vater: analysis of the whole genome sequence exposes a potential therapeutic vulnerability","volume":"4","author":"Demeure","year":"2012","journal-title":"Genome Med"},{"key":"10.1016\/j.cll.2018.03.002_bib41","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/modpathol.2012.122","article-title":"MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma","volume":"25","author":"Schultz","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib42","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/his.13254","article-title":"PD-L1 overexpression in ampulla of Vater carcinoma and its pre-invasive lesions","volume":"71","author":"Saraggi","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.cll.2018.03.002_bib43","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cll.2018.03.002_bib44","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1186\/1471-2407-13-505","article-title":"Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization","volume":"13","author":"Hashemi","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cll.2018.03.002_bib45","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ng.2821","article-title":"Somatic mutation of CDKN1B in small intestine neuroendocrine tumors","volume":"45","author":"Francis","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.cll.2018.03.002_bib46","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1172\/JCI67963","article-title":"The genomic landscape of small intestine neuroendocrine tumors","volume":"123","author":"Banck","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cll.2018.03.002_bib47","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11864-014-0294-4","article-title":"Targeting the mTOR signaling pathway in neuroendocrine tumors","volume":"15","author":"Chan","year":"2014","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.cll.2018.03.002_bib48","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/1078-0432.CCR-15-0373","article-title":"Prognostic impact of novel molecular subtypes of small intestinal neuroendocrine tumor","volume":"22","author":"Karpathakis","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cll.2018.03.002_bib49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/cncr.20750","article-title":"Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors","volume":"103","author":"Kidd","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.cll.2018.03.002_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.humpath.2017.10.003","article-title":"Expression of PD-1 and PD-L1 in poorly differentiated neuroendocrine carcinomas of the digestive system: a potential target for anti-PD-1\/PD-L1 therapy","volume":"70","author":"Roberts","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib51","doi-asserted-by":"crossref","first-page":"e3004","DOI":"10.1038\/cddis.2017.401","article-title":"Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading","volume":"8","author":"Cavalcanti","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.cll.2018.03.002_bib52","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1245\/s10434-012-2238-1","article-title":"Importance of histologic subtype in the staging of appendiceal tumors","volume":"19","author":"Turaga","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.cll.2018.03.002_bib53","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.5858\/arpa.2011-0034-RA","article-title":"Mucinous neoplasms of the appendix and peritoneum","volume":"135","author":"Panarelli","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cll.2018.03.002_bib54","series-title":"WHO classification of tumours of the digestive system","first-page":"122","article-title":"Adenocarcinoma of the appendix","author":"Carr","year":"2010"},{"key":"10.1016\/j.cll.2018.03.002_bib55","series-title":"AJCC cancer staging manual","first-page":"237","article-title":"Appendix \u2013 carcinoma","author":"Overman","year":"2016"},{"key":"10.1016\/j.cll.2018.03.002_bib56","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","article-title":"A\u00a0consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process","volume":"40","author":"Carr","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib57","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cll.2018.03.002_bib58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jss.2012.10.053","article-title":"Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosis","volume":"180","author":"Shetty","year":"2013","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.cll.2018.03.002_bib59","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1634\/theoncologist.2013-0186","article-title":"Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas","volume":"18","author":"Raghav","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.cll.2018.03.002_bib60","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3109\/00365521.2011.565070","article-title":"Ki-ras gene mutations are invariably present in low-grade mucinous tumors of the vermiform appendix","volume":"46","author":"Zauber","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cll.2018.03.002_bib61","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrclinonc.2009.237","article-title":"Microsatellite instability in colorectal cancer-the stable evidence","volume":"7","author":"Vilar","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.cll.2018.03.002_bib62","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/sj.onc.1207194","article-title":"Loss of chromosome 18q and DPC4 (Smad4) mutations in appendiceal adenocarcinomas","volume":"23","author":"Maru","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.cll.2018.03.002_bib63","doi-asserted-by":"crossref","first-page":"164","DOI":"10.21037\/jgo.2017.01.14","article-title":"Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in\u00a0situ hybridization, and mutational analysis","volume":"8","author":"Borazanci","year":"2017","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.cll.2018.03.002_bib64","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1245\/s10434-012-2241-6","article-title":"Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasm","volume":"19","author":"Austin","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.cll.2018.03.002_bib65","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/modpathol.3880572","article-title":"Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations","volume":"15","author":"Kabbani","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib66","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1634\/theoncologist.2014-0106","article-title":"FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma","volume":"19","author":"Pietrantonio","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.cll.2018.03.002_bib67","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/bjc.2013.47","article-title":"Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms","volume":"108","author":"Nishikawa","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cll.2018.03.002_bib68","doi-asserted-by":"crossref","first-page":"E282","DOI":"10.1002\/ijc.29245","article-title":"Genomic profile of pseudomyxoma peritonei analyzed using next-generation sequencing and immunohistochemistry","volume":"136","author":"Nummela","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cll.2018.03.002_bib69","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.humpath.2014.04.018","article-title":"GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival","volume":"45","author":"Singhi","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib70","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/gm559","article-title":"Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin","volume":"6","author":"Alakus","year":"2014","journal-title":"Genome Med"},{"key":"10.1016\/j.cll.2018.03.002_bib71","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1373\/clinchem.2014.225565","article-title":"Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations","volume":"60","author":"Liu","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.cll.2018.03.002_bib72","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/cam4.542","article-title":"Molecular profiles of high-grade and low-grade pseudomyxoma peritonei","volume":"4","author":"Noguchi","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.cll.2018.03.002_bib73","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/PAS.0000000000000194","article-title":"Loss of SMAD4 protein expression is associated with high tumor grade and poor prognosis in disseminated appendiceal mucinous neoplasms","volume":"38","author":"Davison","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib74","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.prp.2015.06.004","article-title":"A\u00a0mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix","volume":"211","author":"Hara","year":"2015","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.cll.2018.03.002_bib75","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/modpathol.2014.37","article-title":"Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade","volume":"27","author":"Davison","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib76","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/annonc\/mdw314","article-title":"Toward the molecular dissection of peritoneal pseudomyxoma","volume":"27","author":"Pietrantonio","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cll.2018.03.002_bib77","doi-asserted-by":"crossref","first-page":"e0174898","DOI":"10.1371\/journal.pone.0174898","article-title":"Multiple components of PKA and TGF-\u03b2 pathways are mutated in pseudomyxoma peritonei","volume":"12","author":"Saarinen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cll.2018.03.002_bib78","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000443165","article-title":"ENETS consensus guidelines for neuroendocrine neoplasms of the appendix (excluding goblet cell carcinomas)","volume":"103","author":"Pape","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.cll.2018.03.002_bib79","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/hupa.2002.32219","article-title":"Different patterns of 11q allelic losses in digestive endocrine tumors","volume":"33","author":"D\u2019adda","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib80","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/01.MP.0000097362.10330.B1","article-title":"Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors","volume":"16","author":"Stancu","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib81","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1053\/paor.1999.0193","article-title":"Morphological-histochemical study of intestinal carcinoids and K-ras mutation analysis in appendiceal carcinoids","volume":"5","author":"Paraskevakou","year":"1999","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.cll.2018.03.002_bib82","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1097-0142(19990701)86:1<14::AID-CNCR4>3.0.CO;2-X","article-title":"K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix","volume":"86","author":"Ramnani","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.cll.2018.03.002_bib83","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.prp.2014.01.002","article-title":"EGFR, KRAS, BRAF-mutations and microsatellite instability are absent in goblet cell carcinoids of the appendix","volume":"210","author":"Dimmler","year":"2014","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.cll.2018.03.002_bib84","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.sla.0000217617.06782.d5","article-title":"Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed","volume":"244","author":"Modlin","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.cll.2018.03.002_bib85","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1245\/ASO.2006.12.011","article-title":"The role of genetic markers\u2013NAP1L1, MAGE-D2, and MTA1\u2013in defining small-intestinal carcinoid neoplasia","volume":"13","author":"Kidd","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.cll.2018.03.002_bib86","doi-asserted-by":"crossref","DOI":"10.1038\/modpathol.2017.184","article-title":"Appendiceal goblet cell carcinoids and adenocarcinomas ex-goblet cell carcinoid are genetically distinct from primary colorectal-type adenocarcinoma of the appendix","author":"Jesinghaus","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib87","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4240\/wjgs.v8.i10.660","article-title":"Goblet cell carcinoids of the appendix: tumor biology, mutations and management strategies","volume":"8","author":"Shenoy","year":"2016","journal-title":"World J Gastrointest Surg"},{"key":"10.1016\/j.cll.2018.03.002_bib88","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1097\/PAS.0b013e31806bee6d","article-title":"A\u00a0comprehensive study of nondysplastic and dysplastic serrated polyps of the vermiform appendix","volume":"31","author":"Yantiss","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib89","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1309\/AJCP1UJPX6UURLCH","article-title":"Serrated lesions of the appendix: a morphologic and immunohistochemical appraisal","volume":"133","author":"Bellizzi","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cll.2018.03.002_bib90","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.humpath.2013.10.021","article-title":"Serrated lesions of the appendix frequently harbor KRAS mutations and not BRAF mutations indicating a distinctly different serrated neoplastic pathway in the appendix","volume":"45","author":"Pai","year":"2014","journal-title":"Hum Pathol"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271218300118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271218300118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T14:03:42Z","timestamp":1534860222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271218300118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0272271218300118"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2018.03.002","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Diagnostics in the Neoplasms of Small Intestine and Appendix","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2018.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}